Role of nitric oxide in the development of tolerance to diazepam-induced motor impairment in mice.
Chronic treatment with the benzodiazepines is well known to produce tolerance, which has been extensively documented to be attributed to modifications in the gamma-aminobutyric acid (GABA)ergic neurotransmission. However, literature data have also suggested the participation of different neurotransmitter systems, including glutamatergic, in benzodiazepine tolerance. The purpose of the present study was to determine the role of nitric oxide (NO) in the development of tolerance to the motor dysfunction induced by chronic administration of diazepam. The motor performance was assessed on the 1st and 10th day of experiment, using the rotarod and chimney tests in mice. Treatment of animals with both non-selective NO synthase (NOS) inhibitors: N(G)-nitro-L-arginine methyl ester (L-NAME), N(G)-nitro-L-arginine (L-NOARG) and selective NOS inhibitor: 7-nitroindazole was able to prevent the development of tolerance to the motor impairing effect of diazepam. Moreover, administration of L-arginine, a NO precursor, facilitated the development of diazepam-induced tolerance in rotarod test. These findings suggest that NO may be involved, at least in part, in the tolerance to the motor dysfunction, developed during the chronic administration of diazepam in mice.
Talarek
Sylwia
S
Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Staszica 4, PL 20-081 Lublin, Poland. sylwia.talarek@am.lublin.pl
Listos
Joanna
J
Fidecka
Sylwia
S
D000818:Animals; D000927:Anticonvulsants / Q000037:antagonists & inhibitors / Q000633:toxicity*; D003975:Diazepam / Q000037:antagonists & inhibitors / Q000633:toxicity*; D004361:Drug Tolerance; D004791:Enzyme Inhibitors / Q000494:pharmacology; D016166:Free Radical Scavengers / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D019335:Nitroarginine / Q000494:pharmacology*; D045442:Rotarod Performance Test
D000927:Anticonvulsants; D004791:Enzyme Inhibitors; D016166:Free Radical Scavengers; D019335:Nitroarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D003975:Diazepam; D019331:NG-Nitroarginine Methyl Ester